Nitric Oxide clinical trials

Explore recruiting nitric oxide clinical trials.

Recruiting nitric oxide studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nitric Oxide trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicentre, Randomized, Double-Blind, Placebo Controlled, Dose Finding, Parallel Group, Phase 2 study of an anti-TSLP Antibody (GSK5784283) in Adults aged 18 to 75 years of age with Uncontrolled Asthma

Bulgaria, Czechia, Germany, Spain, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants with Severe Asthma (VALIANT)

Czechia, Poland, Italy, Germany, Bulgaria, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/2a Trial to Evaluate the Safety, Tolerability and Efficacy of Nebulised RESP30X Nitric Oxide Formulations in Non-Cystic Fibrosis Bronchiectasis (NCFB) Patients with Pseudomonas Aeruginosa (Pa) or other Potentially Pathogenic Micro-organisms (PPMs).

Romania, Bulgaria, Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Role of inhaled nitric oxide on right ventricular function and pulmonary vascular mechanics following cardiac surgery

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled on inhaled corticosteroid and long-acting beta 2 agonist therapy

Czechia, Bulgaria, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Impact of dapagliflozin on vascular function in chronic kidney disease patients - (DAPA-VASC)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nitric Oxide trials by city

Nitric Oxide in Toronto Nitric Oxide in Vancouver Nitric Oxide in Montreal Nitric Oxide in Calgary Nitric Oxide in Edmonton Nitric Oxide in Ottawa Nitric Oxide in Winnipeg Nitric Oxide in Quebec City Nitric Oxide in Hamilton Nitric Oxide in Kitchener Nitric Oxide in London Nitric Oxide in Halifax Nitric Oxide in New York Nitric Oxide in Los Angeles Nitric Oxide in Chicago Nitric Oxide in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease